Correlation Between Pharmaceuticals Ultrasector and Principal Lifetime
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Principal Lifetime at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Principal Lifetime into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Principal Lifetime Hybrid, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Principal Lifetime and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Principal Lifetime. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Principal Lifetime.
Diversification Opportunities for Pharmaceuticals Ultrasector and Principal Lifetime
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pharmaceuticals and Principal is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Principal Lifetime Hybrid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Principal Lifetime Hybrid and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Principal Lifetime. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Principal Lifetime Hybrid has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Principal Lifetime go up and down completely randomly.
Pair Corralation between Pharmaceuticals Ultrasector and Principal Lifetime
Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 2.03 times more return on investment than Principal Lifetime. However, Pharmaceuticals Ultrasector is 2.03 times more volatile than Principal Lifetime Hybrid. It trades about 0.1 of its potential returns per unit of risk. Principal Lifetime Hybrid is currently generating about 0.1 per unit of risk. If you would invest 2,265 in Pharmaceuticals Ultrasector Profund on September 12, 2024 and sell it today you would earn a total of 458.00 from holding Pharmaceuticals Ultrasector Profund or generate 20.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pharmaceuticals Ultrasector Pr vs. Principal Lifetime Hybrid
Performance |
| Timeline |
| Pharmaceuticals Ultrasector |
| Principal Lifetime Hybrid |
Pharmaceuticals Ultrasector and Principal Lifetime Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pharmaceuticals Ultrasector and Principal Lifetime
The main advantage of trading using opposite Pharmaceuticals Ultrasector and Principal Lifetime positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Principal Lifetime can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Principal Lifetime will offset losses from the drop in Principal Lifetime's long position.The idea behind Pharmaceuticals Ultrasector Profund and Principal Lifetime Hybrid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Principal Lifetime vs. Scharf Global Opportunity | Principal Lifetime vs. Arrow Managed Futures | Principal Lifetime vs. T Rowe Price | Principal Lifetime vs. Volumetric Fund Volumetric |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |